Cardinal Health price target raised to $127 from $119 at Morgan Stanley

Morgan Stanley analyst Erin Wright raised the firm’s price target on Cardinal Health (CAH) to $127 from $119 and keeps an Overweight rating on the shares. After Cardinal raised its FY25 EPS guidance to $7.75-$7.90 from $7.55-$7.70, the firm tells investors in a post-earnings recap that it was “pleased by the notable F1Q operational upside and guidance lift with broad-based strength across core pharma subsegments.”